Acasti Pharma, Inc. - Common Stock (NQ:ACST)

3.370 UNCHANGED

Last Price Updated: 3:44 PM EDT, Oct 25, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Acasti Pharma, Inc. - Common Stock

< Previous 1 2 3 Next >

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

September 20, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

September 16, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Recap: Acasti Pharma Q4 Earnings ↗

June 23, 2023

Via Benzinga

Acasti Pharma's Earnings Outlook ↗

February 13, 2023

Via Benzinga

ACST Stock Earnings: Acasti Pharma Beats EPS for Q1 2025 ↗

August 09, 2024

ACST stock results show that Acasti Pharma beat analyst estimates for earnings per share the first quarter of 2025.

Via InvestorPlace

ACST Stock Earnings: Acasti Pharma Beats EPS for Q4 2024 ↗

June 21, 2024

ACST stock results show that Acasti Pharma beat analyst estimates for earnings per share the fourth quarter of 2024.

Via InvestorPlace

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024 ↗

June 18, 2024

Discover top strong buy penny stocks, poised for impressive gains as market indices climb, offering unique opportunities.

Via InvestorPlace

The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom ↗

May 23, 2024

These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress.

Via InvestorPlace

Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 26, 2023

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...

Via Benzinga

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 18, 2024

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the...

Via Benzinga

Why Acasti Pharma (ACST) Stock Is Exploding Higher ↗

September 26, 2023

Acasti Pharma Inc (NASDAQ: ACST) shares are trading higher by 34.3% to $2.35 Tuesday morning after the company announced $7.5 million in private placement equity financing.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

May 09, 2023

We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday!

Via InvestorPlace

Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 05, 2023

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 22, 2023

The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning!

Via InvestorPlace

Acasti Pharma Reports Third Quarter 2023 Operational Results

February 14, 2023

From Acasti Pharma, Inc.

Via GlobeNewswire

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

January 25, 2023

From Acasti Pharma, Inc.

Via GlobeNewswire

Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31

January 24, 2023

From Acasti Pharma, Inc.

Via GlobeNewswire

Earnings Scheduled For February 14, 2023 ↗

February 14, 2023

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.

Via Benzinga

Acasti Pharma Discusses Positive Clinical Study Results for GTX-101 and GTX-102 and Upcoming Phase 3 Study for GTX-104 with The Stock Day Podcast

January 17, 2023

Phoenix, Arizona--(Newsfile Corp. - January 17, 2023) - The Stock Day Podcast welcomed Acasti Pharma, Inc. (NASDAQ: ACST), a late-stage...

Via Newsfile

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

January 13, 2023

From Acasti Pharma, Inc.

Via GlobeNewswire

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket ↗

January 06, 2023

Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 06, 2023

The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday!

Via InvestorPlace

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

January 05, 2023

From Acasti Pharma, Inc.

Via GlobeNewswire

Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia

December 28, 2022

From Acasti Pharma, Inc.

Via GlobeNewswire

Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

December 23, 2022

Gainers

Via Benzinga

Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket ↗

December 23, 2022

Gainers Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer...

Via Benzinga

Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)

December 22, 2022

From Acasti Pharma, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 ↗

December 19, 2022

Via Benzinga

Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022 ↗

December 15, 2022

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.